前往化源商城

Journal of Clinical Epidemiology 2013-12-01

Physicians' prescribing preferences were a potential instrument for patients' actual prescriptions of antidepressants.

Neil M Davies, David Gunnell, Kyla H Thomas, Chris Metcalfe, Frank Windmeijer, Richard M Martin

文献索引:J. Clin. Epidemiol. 66(12) , 1386-96, (2013)

全文:HTML全文

摘要

To investigate whether physicians' prescribing preferences were valid instrumental variables for the antidepressant prescriptions they issued to their patients.We investigated whether physicians' previous prescriptions of (1) tricyclic antidepressants (TCAs) vs. selective serotonin reuptake inhibitors (SSRIs) and (2) paroxetine vs. other SSRIs were valid instruments. We investigated whether the instrumental variable assumptions are likely to hold and whether TCAs (vs. SSRIs) were associated with hospital admission for self-harm or death by suicide using both conventional and instrumental variable regressions. The setting for the study was general practices in the United Kingdom.Prior prescriptions were strongly associated with actual prescriptions: physicians who previously prescribed TCAs were 14.9 percentage points (95% confidence interval [CI], 14.4, 15.4) more likely to prescribe TCAs, and those who previously prescribed paroxetine were 27.7 percentage points (95% CI, 26.7, 28.8) more likely to prescribe paroxetine, to their next patient. Physicians' previous prescriptions were less strongly associated with patients' baseline characteristics than actual prescriptions. We found no evidence that the estimated association of TCAs with self-harm/suicide using instrumental variable regression differed from conventional regression estimates (P-value = 0.45).The main instrumental variable assumptions held, suggesting that physicians' prescribing preferences are valid instruments for evaluating the short-term effects of antidepressants.Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

相关化合物

结构式 名称/CAS号 全部文献
帕罗西汀 马来酸盐 结构式 帕罗西汀 马来酸盐
CAS:64006-44-6
盐酸帕罗西汀 结构式 盐酸帕罗西汀
CAS:78246-49-8